US equities |
TSLA $391.62 ▲+5.21% MU $903.70 ▲+2.98% META $630.56 ▼-1.88% NVDA $216.00 ▲+2.39% AAPL $343.91 ▼-1.10% SPCX $146.90 ▼-0.40% MSFT $532.60 ▲+1.54% AMD $531.28 ▲+2.80%
FinancialContent

Currenc Group Inc. - Ordinary Shares (OP:CURR)

N/A UNCHANGED
Last Price Updated: 3:04 PM EDT, Aug 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Currenc Group Inc. - Ordinary Shares

< Previous 1 2 Next >
News headline image
Avenir Wellness Solutions Reports Third Quarter 2023 Results
Via ACCESSWIRE
News headline image
Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
Via ACCESSWIRE
News headline image
Avenir Wellness Solutions Reports First Quarter 2023 Results with Strong Sequential and Year Over Year Revenue Increases and Continued High Gross Margins
Via ACCESSWIRE
News headline image
Avenir Wellness Solutions Update to Stockholders
Via ACCESSWIRE
Wide Marketing and Shipments Commenced for New Patent Pending DNA Complex Skin Care Used by Top Movie and TV Star Nicole Kidman: Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
Via Get News
Topics Intellectual Property
News headline image
Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available
Via ACCESSWIRE
News headline image
Avenir Wellness Letter to Stockholders
Via ACCESSWIRE
News headline image
Avenir's Sera Labs Launches Patent Pending DNA Complex with Advanced Peptides and Compounds - Providing Instant and Long-Lasting Results With Daily Use
Via ACCESSWIRE
News headline image
CURE Pharmaceutical Unveils Exciting New Brand Identity with Name Change to Avenir Wellness Solutions, Inc.
Via ACCESSWIRE
News headline image
CURE Pharmaceutical Letter to Shareholders
Via ACCESSWIRE
Most Powerful Anti-Aging Product Lines with Patent Pending DNA Complex; Endorsed by Oscars Night 2023 Presenter Nicole Kidman: Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
Via Get News
Topics Intellectual Property
News headline image
Avenir Wellness Solutions, Inc. Gains High Profile Exposure on theSkimm Social Media Platform With 7 Million Followers and Launches New Website in Support of Corporate Rebranding
Via ACCESSWIRE
Nicole Kidman Endorsed Wellness and Beauty Products; On-Track for Accelerated Sales Growth with Company Rebranded as Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
Via Get News
Topics Intellectual Property
News headline image
Avenir Wellness Solutions to Launch Wall Street-focused Informational Series with Producer New to The Street
Via ACCESSWIRE
News headline image
CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins
Via ACCESSWIRE
Anti-Aging Wellness Products; Q3 Revenues Surge; $20 Million non-dilutive IP Asset Sale: Cure Pharmaceutical Inc. (Stock Symbol: CURR)
Via Get News
Topics Intellectual Property
$20 Million Cash Gain from Partial IP Asset Sale and Strong Financial Growth with Projected Acceleration: CURE Pharmaceutical: (Stock Symbol: CURR)
Via Get News
CURE Pharmaceuticals Holding Corp. (CURR) Featured in Virtual Coverage of NIBA’s 148th Investment Conference
Via Investor Brand Network
Topics Intellectual Property
$20 Million sale of IP Platform Technology; Health and Beauty Lines Available at Walmart, Bed Bath & Beyond, CVS & Target.com: CURE Pharmaceutical (Stock Symbol: CURR)
Via Get News
Topics Intellectual Property
Marketing Partnerships for Advanced Health and Beauty Lines; Products Available at Walmart, Bed Bath & Beyond, CVS & Target.com: CURE Pharmaceutical (Stock Symbol: CURR)
Via Get News
Topics Intellectual Property
News headline image
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV
LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at... 
From Stock News Now
Via AccessWire
Patented Oral Thin Film Drug Delivery Advancements with Applications on Key Health & Beauty Products; Partnered with Super Star Nicole Kidman: CURE Pharmaceutical (OTCQB: CURR)
Via Get News
News headline image
CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines
From CURE Pharmaceutical Holding Corp.
Via Business Wire
News headline image
CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference
From CURE Pharmaceutical Holding Corp.
Via Business Wire
News headline image
CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health
From CURE Pharmaceutical Holding Corp.
Via Business Wire
News headline image
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be... 
From Stock News Now
Via AccessWire
Topics Cannabis
News headline image
Nicole Kidman and Sera Labs Inc., a CURE Pharmaceutical Company, Launch Seratopical Revolution and New Ad Campaign
From Sera Labs
Via Business Wire
News headline image
CURE Pharmaceutical Schedules Investor Webcast for Thursday, May 27, 2021
From CURE Pharmaceutical Holding Corp.
Via Business Wire
News headline image
CURE Pharma (Stock Symbol: CURR) Q1 Revenue Quadruples to $1.5 million; Marketing Strength Grows with ISO Certification
(Stock Symbol: CURR), Sees Q1 Revenues Jump Fourfold; Marketing Strength Grows with Recent ISO Certification and Expansion of New Biopharma Product Lines 
Via EIN Presswire
News headline image
CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Psychedelics
From CURE Pharmaceutical Holding Corp.
Via Business Wire
< Previous 1 2 Next >